Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9257610 | Critical Reviews in Oncology/Hematology | 2005 | 7 Pages |
Abstract
In view of these recent results, the goals of this review are as follows: (1) to provide background on the mandate for further study of the cancer-associated anorexia/weight loss syndrome; (2) to review the preliminary data that have suggested that eicosapentaenoic acid is a promising agent for treating this syndrome; (3) to review the methodology and findings of the more recent, definitive clinical trials; (4) to discuss and speculate on why the earlier positive findings drew conclusions that are discrepant from the results of more recent comparative clinical studies.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Aminah Jatoi,